高级检索
    周彩存, 徐崇锐. 原位RRM1和ERCC1蛋白表达水平预测吉西他滨为基础化疗方案对非小细胞肺癌的疗效[J]. 循证医学, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
    引用本文: 周彩存, 徐崇锐. 原位RRM1和ERCC1蛋白表达水平预测吉西他滨为基础化疗方案对非小细胞肺癌的疗效[J]. 循证医学, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
    shu
    ZHOU Cai-chun, XU Chong-rui. Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
    Citation: ZHOU Cai-chun, XU Chong-rui. Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
    shu

    原位RRM1和ERCC1蛋白表达水平预测吉西他滨为基础化疗方案对非小细胞肺癌的疗效

    Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回